CD8B and systemic lupus erythematosus: More specifically, MHC-I signaling was prominent in ligand–receptor interactions of HLA class I molecules with CD8A, CD8B and KLRK1, while Galectin signaling was primarily mediated between LGALS9 (a biomarker in SLE pathogenesis50) and CD45 (Fig. 3h).